Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Contralateral
100%
Tension-Free Vaginal Tape Procedure
94%
Clear Cell Renal Cell Carcinoma
94%
Diseases
81%
Nephrectomy
78%
Prostatectomy
69%
Prostate Hypertrophy
69%
Tumor
60%
Stress Incontinence
52%
Transrectal Ultrasonography
50%
Multicystic Dysplastic Kidney
47%
Wilms' Tumor
47%
Bladder
44%
Peroperative Complication
41%
Metastatic Carcinoma
39%
Transurethral Resection
37%
Urinary Tract
36%
Abdominal Mass
36%
Myocardial Infarction
36%
Partial Nephrectomy
34%
Computer Assisted Tomography
34%
Urinary System
33%
Solitary Kidney
31%
Ectopic Tissue
31%
Angiomyolipoma
31%
Ganglioneuroblastoma
31%
Blood Pressure Monitoring
31%
Patient with Wilms' Tumor
31%
Immunotherapy
31%
Surgical Margin
31%
Uninephrectomy
31%
Urethra Diverticulum
31%
Strangury
31%
Prostate Disease
31%
Low Drug Dose
31%
Interleukin 2
31%
Kidney Metastasis
31%
Cloaca
31%
Involution
31%
Neonatal Infant
31%
Incidental Finding
31%
Subcutaneous Injection
31%
Kidney Dysplasia
31%
Prenatal Diagnosis
31%
Corpus Cavernosum Penis
31%
Rectum Carcinoma
31%
Adrenal Gland
31%
Sexual Behavior
31%
Spontaneous Remission
31%
Photograph
31%
Keyphrases
Tension-free Vaginal Tape
94%
Renal Cell Carcinoma
86%
Kidney
83%
Nephrectomy
82%
Wilms Tumor
63%
Urethra
61%
Tumor
44%
Vesicoureteral Reflux
42%
Treatment Strategy
42%
Associated Complications
39%
Multicystic Dysplastic Kidney
39%
Incidental
39%
Computed Tomography
38%
Female Urinary Incontinence
37%
Urologic
36%
Partial Nephrectomy
36%
Stress Urinary Incontinence
36%
Operative
33%
Multicystic Kidney
31%
Renal Cell Carcinoma Metastasis
31%
Posterior Cloaca
31%
Intrarenal Neuroblastoma
31%
Penile Girth Enhancement
31%
Liquid Injectable Silicone
31%
Transvaginal Tape
31%
Cotrimoxazole
31%
Cefixime
31%
Benign Prostatic Hyperplasia
31%
Bowel Control
31%
Cephalexin
31%
Open Resection
31%
Interleukin-2
31%
Neuroblastoma
31%
Metachronous
31%
Short-term Outcomes
31%
Prostatic Diseases
31%
Transurethral Resection of Prostate
31%
Disease Course
31%
Improved Diagnosis
31%
Metastatic Renal Cell Carcinoma (mRCC)
31%
Low-dose interleukin-2
31%
Prophylactic Antibiotics
31%
Adrenal Gland
31%
Nalidixic Acid
31%
Masquerade
31%
Growth Inhibition
31%
Open Prostatectomy
31%
Involution
31%
Acute Myocardial Infarction
31%
Patient Weight
31%